Financhill
Back

Denali Therapeutics Stock Price Chart

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DNLI is experiencing selling pressure, which indicates risk of future bearish movement.

Denali Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 21.4 Sell
20-day SMA: 23.04 Sell
50-day SMA: 25.37 Sell
200-day SMA: 23.05 Sell
8-day EMA: 21.48 Sell
20-day EMA: 22.78 Sell
50-day EMA: 24.48 Sell
200-day EMA: 23.98 Sell

Denali Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.33 Sell
Relative Strength Index (14 RSI): 30.74 Sell
Chaikin Money Flow: -479642 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.83 - 24.89) Sell
Bollinger Bands (100): (23.11 - 28.65) Sell

Denali Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Denali Therapeutics Stock

Is Denali Therapeutics Stock a Buy?

DNLI Technical Analysis vs Fundamental Analysis

Sell
18
Denali Therapeutics (DNLI) is a Sell

Is Denali Therapeutics a Buy or a Sell?

Denali Therapeutics Stock Info

Market Cap:
3B
Price in USD:
20.61
Share Volume:
602.2K

Denali Therapeutics 52-Week Range

52-Week High:
33.33
52-Week Low:
14.56
Sell
18
Denali Therapeutics (DNLI) is a Sell

Denali Therapeutics Share Price Forecast

Is Denali Therapeutics Stock a Buy?

  • Denali Therapeutics share price is 20.61 while DNLI 8-day exponential moving average is 21.48, which is a Sell signal.
  • The stock price of DNLI is 20.61 while Denali Therapeutics 20-day EMA is 22.78, which makes it a Sell.
  • Denali Therapeutics 50-day exponential moving average is 24.48 while DNLI share price is 20.61, making it a Sell technically.
  • DNLI stock price is 20.61 and Denali Therapeutics 200-day simple moving average is 23.98, creating a Sell signal.

Fundamental Analysis of Denali Therapeutics

Is Denali Therapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.84 per share, and a decrease next year of $0.15 per share.

Technical Analysis of Denali Therapeutics

Should I short Denali Therapeutics stock?

* Denali Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.